Kevin Heal Analyst PerformanceManaging Director at ArgusKevin Heal is a stock analyst at Argus focused in the finance sector, covering 10 publicly traded companies. Over the past year, Kevin Heal has issued 9 stock ratings, including buy and hold recommendations. While full access to Kevin Heal's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kevin Heal's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings14 Last 5 YearsBuy Recommendations81.82% 9 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution11RatingsDistribution of strong buy, buy, hold, and sell ratings by Kevin Heal.RatingPercentageCount Strong Buy0.0%0 ratings Buy81.8%9 ratings Hold18.2%2 ratings Sell0.0%0 ratingsOut of 11 total stock ratings issued by Kevin Heal at Argus, the majority (81.8%) have been Buy recommendations, followed by 18.2% Hold.Best & Worst CallsBest Call0000.0%CLSApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RITMJul 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE70.0% of companies on NYSE7 companiesNASDAQ30.0% of companies on NASDAQ3 companiesKevin Heal, an analyst at Argus, currently covers 10 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageFinance9 companies90.0%Computer and Technology1 company10.0%Kevin Heal of Argus specializes in stock coverage within the Finance sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageINS - PROP&CASLTY3 companies30.0%FIN - MISC SVCS2 companies20.0%FIN - INVEST BKRS1 company10.0%BANKS - NORTHEAST1 company10.0%FIN - INVEST MGMT1 company10.0%ELEC MANUF SVS (EMS)1 company10.0%BANKS - MIDWEST1 company10.0% About Kevin HealKevin manages the day-to-day operations of ARG’s SEC registered investment advisor, Argus Investors’ Counsel. As CCO, he is responsible for ensuring that the firm is SEC compliant and adheres to all rules and regulations. He serves on the Argus Investment Committee, providing insight on the fixed-income markets and interest rates. Kevin also provides equity coverage for financial institutions including Insurance, Exchanges, Regional Banks, Data Providers, Asset Managers, Mortgage Originators, and REITs. He has over 35 years of experience with large investment banks, regional dealers, and consultants. Kevin graduated from Northwestern University with a BA in Economics and maintains the Series 65 registration.Follow on LinkedIn Kevin Heal's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMKTXMarketAxess3/17/2026Downgrade$180.33Hold$0.0000.00% ROIWRBW.R. Berkley2/2/2026Lower Price Target$67.77$76.00Buy$0.0000.00% ROICFGCitizens Financial Group1/23/2026Boost Price Target$63.43$72.00Buy$0.0000.00% ROIMKTXMarketAxess12/17/2025Lower Price Target$179.47$205.00Buy$0.0000.00% ROICOINCoinbase Global11/25/2025Reiterated Rating$255.97Hold$0.0000.00% ROIHIGThe Hartford Insurance Group11/25/2025Boost Price Target$138.07$155.00Buy$0.0000.00% ROIAMPAmeriprise Financial11/13/2025Lower Price Target$465.05$554.00Buy$0.0000.00% ROIMKTXMarketAxess8/25/2025Upgrade$188.73$212.00Buy$0.0000.00% ROICOINCoinbase Global7/14/2025Initiated Coverage$387.06$400.00Buy$0.0000.00% ROICLSCelestica4/29/2025Lower Price Target$86.99$120.00Buy$000.0000.00% ROIHBANHuntington Bancshares4/25/2025Set Price Target$14.46$17.00$00.0000.00% ROICFGCitizens Financial Group4/24/2025Set Price Target$36.96$45.00$00.0000.00% ROIBRK.BBerkshire Hathaway3/26/2025Set Price Target$532.87$575.00$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
